PlainRecalls
FDA Devices Moderate Class II Ongoing

Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.

Reported: August 4, 2021 Initiated: June 7, 2021 #Z-2136-2021

Product Description

Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.

Reason for Recall

During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Details

Recalling Firm
Medtronic Vascular, Inc.
Units Affected
21 devices
Distribution
U.S.: GA, MA, MD, NY, SC, TX, WA, and WV O.U.S.: Argentina, Australia, Germany, Greece, Israel, Italy, Netherlands, Poland, South Africa, Spain, Switzerland and United Kingdom.
Location
Santa Rosa, CA

Frequently Asked Questions

What product was recalled?
Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.. Recalled by Medtronic Vascular, Inc.. Units affected: 21 devices.
Why was this product recalled?
During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 4, 2021. Severity: Moderate. Recall number: Z-2136-2021.